Page last updated: 2024-08-16

rofecoxib and arachidonic acid

rofecoxib has been researched along with arachidonic acid in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Bohlin, L; Huss, U; Perera, P; Ringbom, T; Vasänge, M1
Boyce, S; Brideau, C; Chan, CC; Charleson, S; Cromlish, W; Ethier, D; Evans, J; Ford-Hutchinson, AW; Forrest, MJ; Gauthier, JY; Gordon, R; Gresser, M; Guay, J; Kargman, S; Kennedy, B; Leblanc, Y; Leger, S; Mancini, J; O'Neill, GP; Ouellet, M; Patrick, D; Percival, MD; Perrier, H; Prasit, P; Rodger, I1
Kessenich, CR1
Nervetti, A; Rioda, WT1
Capriotti, T1
Sharma, RA1
Al-Falaki, O; Blaicher, AM; Gruber, D; Hoerauf, K; Landsteiner, HT; Volf, I; Zimpfer, M; Zwerina, J1
Arderiu, G; Escolar, G; Hernandez, MR; Pino, M; Serradell, M; Tonda, R1
Bühler, MI; Ortiz, ME; Zelarayán, LI1
Aghazadeh-Habashi, A; Asghar, W; Jamali, F1
Alqudah, M; Askar, N; Gharaibeh, M; Jarrar, Y1

Reviews

4 review(s) available for rofecoxib and arachidonic acid

ArticleYear
Cyclo-oxygenase 2 inhibitors: an important new drug classification.
    Pain management nursing : official journal of the American Society of Pain Management Nurses, 2001, Volume: 2, Issue:1

    Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Forecasting; Humans; Inflammation; Isoenzymes; Lactones; Membrane Proteins; Pain; Patient Selection; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides; Sulfones

2001
[Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].
    Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 2001, Volume: 72, Issue:3-4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Isoenzymes; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostaglandins G; Pyrazoles; Rheumatic Diseases; Sulfonamides; Sulfones

2001
The new NSAIDs: cox-2 inhibitors.
    Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, 2000, Volume: 9, Issue:6

    Topics: Advertising; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Industry; Gastrointestinal Diseases; Humans; Isoenzymes; Lactones; Meloxicam; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Safety; Sulfonamides; Sulfones; Thiazines; Thiazoles

2000
Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer.
    QJM : monthly journal of the Association of Physicians, 2002, Volume: 95, Issue:5

    Topics: Arachidonic Acid; Aspirin; Cardiovascular Diseases; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Design; Humans; Isoenzymes; Lactones; Membrane Proteins; Neoplasms; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; Sulfones

2002

Trials

1 trial(s) available for rofecoxib and arachidonic acid

ArticleYear
Acetylsalicylic acid, diclofenac, and lornoxicam, but not rofecoxib, affect platelet CD 62 expression.
    Anesthesia and analgesia, 2004, Volume: 98, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Female; Flow Cytometry; Humans; Isoenzymes; Lactones; Male; Membrane Proteins; Piroxicam; Platelet Function Tests; Prospective Studies; Prostaglandin-Endoperoxide Synthases; Selectins; Sulfones

2004

Other Studies

6 other study(ies) available for rofecoxib and arachidonic acid

ArticleYear
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
    Journal of natural products, 2002, Volume: 65, Issue:11

    Topics: Acrolein; Alkaloids; Animals; Anthraquinones; Aspirin; Biological Assay; Catalysis; Cinnamomum zeylanicum; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Eugenol; Flavonoids; Indomethacin; Inhibitory Concentration 50; Isoenzymes; Kinetics; Lactones; Models, Molecular; Nitrobenzenes; Oleanolic Acid; Plants, Medicinal; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Steroids; Sulfonamides; Sulfones; Syzygium; Terpenes; Triterpenes; Ursolic Acid

2002
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonate 15-Lipoxygenase; Arachidonic Acid; Arthritis, Experimental; Blood Platelets; Cell Line; COS Cells; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Digestive System; Dogs; Edema; Female; Humans; Hyperalgesia; In Vitro Techniques; Isoenzymes; Lactones; Leukotriene B4; Male; Membrane Proteins; Microsomes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Saimiri; Sulfones

1999
Evaluation of effects of rofecoxib on platelet function in an in vitro model of thrombosis with circulating human blood.
    European journal of clinical investigation, 2004, Volume: 34, Issue:4

    Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Blood Platelets; Cell Adhesion; Collagen; Cyclooxygenase Inhibitors; Endothelium; Humans; Lactones; Platelet Aggregation; Sulfones; Thrombosis

2004
Involvement of PLA2, COX and LOX in Rhinella arenarum oocyte maturation.
    Zygote (Cambridge, England), 2014, Volume: 22, Issue:4

    Topics: Animals; Arachidonic Acid; Bufo arenarum; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Indomethacin; Lactones; Lipoxygenase; Masoprocol; Melitten; Oocytes; Oogenesis; Phospholipases A2; Progesterone; Prostaglandin-Endoperoxide Synthases; Quinacrine; Sulfones

2014
Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid.
    Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Experimental; Celecoxib; Cytochrome P-450 Enzyme System; Heart; Hydroxyeicosatetraenoic Acids; Inflammation; Kidney; Lactones; Male; Meloxicam; Rats; Rats, Sprague-Dawley; Sulfones; Thiazines; Thiazoles

2018
Upregulation of Beta 1 and Arachidonic Acid Metabolizing Enzymes in the Mouse Hearts and Kidneys after Sub Chronic Administration of Rofecoxib.
    Current molecular pharmacology, 2023, Volume: 16, Issue:3

    Topics: Animals; Arachidonic Acid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Mice; RNA, Messenger; Up-Regulation

2023